is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives
The maximum dosage for extended-release tablets and liquid solution is 2,000 mg daily
Who Is a Candidate for CJC-1295 and Ipamorelin
Hypersensitivity responses may manifest as urticaria, bronchospasm, or respiratory discomfort, particularly in predisposed individuals
Discard Saxenda if frozen, exposed to temperatures above 30C, cloudy, discoloured, or 30 days after first use
Semaglutide is the only GLP-1 drug available in both oral and subcutaneous dosage forms, providing consumers with the flexibility to choose according to their own needs